1
|
Kerawala C, Roques T, Jeannon JP and
Bisase B: Oral cavity and lip cancer: United kingdom national
multidisciplinary guidelines. J Laryngol Otol. 130((S2)): S83–S89.
2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Du M, Nair R, Jamieson L, Liu Z and Bi P:
Incidence trends of lip, oral cavity, and pharyngeal cancers:
Global burden of disease 1990–2017. J Dent Res. 99:143–151. 2020.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Farquhar DR, Tanner AM, Masood MM, PATEl
SR, Hackman TG, Olshan AF, Mazul AL and Zevallos JP: Oral tongue
carcinoma among young patients: An analysis of risk factors and
survival. Oral Oncol. 84:7–11. 2018. View Article : Google Scholar : PubMed/NCBI
|
4
|
Jou A and Hess J: Epidemiology and
molecular biology of head and neck cancer. Oncol Res Treat.
40:328–332. 2017. View Article : Google Scholar : PubMed/NCBI
|
5
|
Sun Z, Hu S, Luo Q, Ye D, Hu D and Chen F:
Overexpression of SENP3 in oral squamous cell carcinoma and its
association with differentiation. Oncol Rep. 29:1701–1706. 2013.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Sun Z, Luo Q, Ye D, Chen W and Chen F:
Role of toll-like receptor 4 on the immune escape of human oral
squamous cell carcinoma and resistance of cisplatin-induced
apoptosis. Mol Cancer. 11:332012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Rissoan MC, Duhen T, Bridon JM,
Bendriss-Vermare N, Péronne C, de Saint Vis B, Brière F and Bates
EE: Subtractive hybridization reveals the expression of
immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel
transcripts in human plasmacytoid dendritic cells. Blood.
100:3295–3303. 2002. View Article : Google Scholar : PubMed/NCBI
|
8
|
Jimenez-Preitner M, Berney X, Uldry M,
Vitali A, Cinti S, Ledford JG and Thorens B: Plac8 is an inducer of
C/EBPβ required for brown fat differentiation, thermoregulation,
and control of body weight. Cell Metab. 14:658–670. 2011.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Ledford JG, Kovarova M and Koller BH:
Impaired host defense in mice lacking ONZIN. J Immunol.
178:5132–5143. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
El-Sayed A, Hoelker M, Rings F, Jennen DS,
Tholen E, Sirard MA, Schellander K and Tesfaye D: Large-scale
transcriptional analysis of bovine embryo biopsies in relation to
pregnancy success after transfer to recipients. Physiol Genomics.
28:84–96. 2006. View Article : Google Scholar : PubMed/NCBI
|
11
|
Kinsey C, Balakrishnan V, O'Dell MR, Huang
JL, Newman L, Whitney-Miller CL, Hezel AF and Land H: Plac8 links
oncogenic mutations to regulation of autophagy and is critical to
pancreatic cancer progression. Cell Rep. 7:1143–1155. 2014.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Li C, Ma H, Wang Y, Cao V, Graves-Deal R,
Powell AE, Starchenko A, Ayers GD, Washington MK, Kamath V, et al:
Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon
cancer. J Clin Invest. 124:2172–2187. 2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Mao M, Chen Y, Jia Y, Yang J, Wei Q, Li Z,
Chen L, Chen L and Wang L: PLCA8 suppresses breast cancer apoptosis
by activating the PI3k/AKT/NF-κB pathway. J Cell Mol Med.
23:6930–6941. 2019. View Article : Google Scholar : PubMed/NCBI
|
14
|
Kolluru V, Pal D, AMS PJ, Ankem MK,
Freedman JH and Damodaran C: Induction of Plac8 promotes
pro-survival function of autophagy in cadmium-induced prostate
carcinogenesis. Cancer Lett. 408:121–129. 2017. View Article : Google Scholar : PubMed/NCBI
|
15
|
Jia Y, Ying X, Zhou J, Chen Y, Luo X, Xie
S, Wang QC, Hu W and Wang L: The novel KLF4/PLAC8 signaling pathway
regulates lung cancer growth. Cell Death Dis. 9:6032018. View Article : Google Scholar : PubMed/NCBI
|
16
|
Shi L, Xiao L, Heng B, Mo S, Chen W and Su
Z: Overexpression of placenta specific 8 is associated with
malignant progression and poor prognosis of clear cell renal cell
carcinoma. Int Urol Nephrol. 49:1165–1176. 2017. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zou L, Chai J, Gao Y, Guan J, Liu Q and Du
JJ: Down-regulated PLAC8 promotes hepatocellular carcinoma cell
proliferation by enhancing PI3K/Akt/GSK3β/Wnt/β-catenin signaling.
Biomed Pharmacother. 84:139–146. 2016. View Article : Google Scholar : PubMed/NCBI
|
18
|
Togashi Y, Hayashi H, Terashima M, de
Velasco MA, Sakai K, Fujita Y, Tomida S, Nakagawa K and Nishio K:
Inhibition of β-Catenin enhances the anticancer effect of
irreversible EGFR-TKI in EGFR-mutated non-small-cell lung cancer
with a T790M mutation. J Thorac Oncol. 10:93–101. 2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Yao Y, Wu J, Zhou H, Firrman J, Xiao W,
Sun Z and Li D: A deficiency in cathelicidin reduces lung tumor
growth in NNK/NTHi-induced A/J mice. Am J Cancer Res. 8:1190–1199.
2018.PubMed/NCBI
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Li D, Sun J, Liu W, Wang X, Bals R, Wu J,
Quan W, Yao Y, Zhang Y, Zhou H and Wu K: Rig-G is a growth
inhibitory factor of lung cancer cells that suppresses STAT3 and
NF-κB. Oncotarget. 7:66032–66050. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
Zhan T, Rindtorff N and Boutros M: Wnt
signaling in cancer. Oncogene. 36:1461–1473. 2017. View Article : Google Scholar : PubMed/NCBI
|
23
|
Ji P, Zhou Y, Yang Y, Wu J, Zhou H, Quan
W, Sun J, Yao Y, Shang A, Gu C, et al: Myeloid cell-derived LL-37
promotes lung cancer growth by activating Wnt/β-catenin signaling.
Theranostics. 9:2209–2223. 2019. View Article : Google Scholar : PubMed/NCBI
|
24
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
25
|
Sun Z, Liu Q, Ye D, Ye K, Yang Z and Li D:
Role of c-Met in the progression of human oral squamous cell
carcinoma and its potential as a therapeutic target. Oncol Rep.
39:209–216. 2018.PubMed/NCBI
|
26
|
Feng Z, Xu QS, Wang C, Li B, Li JZ, Mao
MH, Li H, Qin Z and Han Z: Clinicopathological features, management
and outcome of patients with poorly-differentiated oral and
oropharyngeal squamous cell carcinoma. J Craniomaxillofac Surg.
45:1478–1485. 2017. View Article : Google Scholar : PubMed/NCBI
|
27
|
Li D, Beisswenger C, Herr C, Hellberg J,
Han G, Zakharkina T, Voss M, Wiewrodt R, Bohle RM, Menger MD, et
al: Myeloid cell RelA/p65 promotes lung cancer proliferation
through Wnt/β-catenin signaling in murine and human tumor cells.
Oncogene. 33:1239–1248. 2014. View Article : Google Scholar : PubMed/NCBI
|
28
|
Kansy BA, Dißmann PA, Hemeda H, Bruderek
K, Westerkamp AM, Jagalski V, Schuler P, Kansy K, Lang S, Dumitru
CA and Brandau S: The bidirectional tumor-mesenchymal stromal cell
interaction promotes the progression of head and neck cancer. Stem
Cell Res Ther. 5:952014. View
Article : Google Scholar : PubMed/NCBI
|
29
|
Böhrnsen F, Fricke M, Sander C, Leha A,
Schliephake H and Kramer FJ: Interactions of human MSC with head
and neck squamous cell carcinoma cell line PCI-13 reduce markers of
epithelia-mesenchymal transition. Clin Oral Investig. 19:1121–1128.
2015. View Article : Google Scholar : PubMed/NCBI
|
30
|
Liu S, Shi L, Wang Y, Ye D, Ju H, Ma H,
Yang W, Wang Y, Hu J, Deng J and Zhang Z: Stabilization of slug by
NF-κB is essential for TNF-α -induced migration and
epithelial-mesenchymal transition in head and neck squamous cell
carcinoma cells. Cell Physiol Biochem. 47:567–578. 2018. View Article : Google Scholar : PubMed/NCBI
|
31
|
Brembeck FH, Rosário M and Birchmeier W:
Balancing cell adhesion and Wnt signaling, the key role of
beta-catenin. Curr Opin Genet Dev. 16:51–59. 2006. View Article : Google Scholar : PubMed/NCBI
|
32
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
33
|
Orsulic S, Huber O, Aberle H, Arnold S and
Kemler R: E-cadherin binding prevents beta-catenin nuclear
localization and beta-catenin/LEF-1-mediated transactivation. J
Cell Sci. 112:1237–1245. 1999.PubMed/NCBI
|
34
|
Li D, Liu W, Wang X, Quan W, Yao Y, Bals
R, Ji S, Wu K, Guo J and Wan H: Cathelicidin, an antimicrobial
peptide produced by macrophages, promotes colon cancer by
activating the Wnt/β-catenin pathway. Oncotarget. 6:2939–2950.
2015. View Article : Google Scholar : PubMed/NCBI
|
35
|
Xue Q, Yu C, Wang Y, Liu L, Zhang K, Fang
C, Liu F, Bian G, Song B, Yang A, et al: miR-9 and miR-124
synergistically affect regulation of dendritic branching via the
AKT/GSK3β pathway by targeting Rap2a. Sci Rep. 6:267812016.
View Article : Google Scholar : PubMed/NCBI
|